Article
Genetic drivers of progression in Alzheimers disease are distinct from disease risk
2025-11-19
Abstract excerpt
<h4>Background: </h4> Recent trials in Alzheimers disease (AD) demonstrate encouraging outcomes. These trials target risk mechanisms identified through genetic analysis whilst directly aiming to reduce progression rates. Evidence from other neurodegenerative diseases suggests the genetics of progression is distinct from risk of disease. To expand these initial successes and improve clinical outcomes further we nee...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 47ae7194-5956-5550-854f-954635e4ce4f
- DOI
- 10.1101/2025.11.17.25340247